MH4 ADHD-RELATED PATIENT AND FAMILY BURDEN: BASELINE RESULTS FROM THE OBSERVATIONAL STUDY ADORE IN GERMANY  by Döpfner, M et al.
648 Abstracts
health states. The scenarios were (A) “good” function with no
movement disorders [extrapyramidal symptoms]; (B) “good”
function with movement disorders; (C) “bad” function with no
movement disorders; (D) “bad” function with movement disor-
ders; (E) hospitalised relapse with no movement disorders; (F)
hospitalised relapse with movement disorders; (G) post-hospi-
talisation with no movement disorders; and (H) post-hospitali-
sation with movement disorders. A utility value between zero
(death) and one (perfect health) for each scenario was calculated
using the AQoL. RESULTS: The mean (±SD) utility values for
each health state scenario from the general population perspec-
tive were [n = 87]: (A) 0.68 ± 0.27; (B) 0.48 ± 0.25; (C) 0.17 ±
0.24; (D) 0.11 ± 0.21; (E) 0.03 ± 0.23; (F) 0.01 ± 0.20; (G) 0.57
± 0.27; and (H) 0.46 ± 0.24. Those for caregivers were [n = 7]:
(A) 0.34 ± 0.18; (B) 0.22 ± 0.22; (C) 0.10 ± 0.20; (D) 0.11 ±
0.22; (E) 0.03 ± 0.10; (F) 0.03 ± 0.13; (G) 0.25 ± 0.22; and (H)
0.31 ± 0.25. The mean (±SD) utility values for the caregivers
themselves were [n = 7]: (A) 0.65 ± 0.14; (B) 0.54 ± 0.29; (C)
0.46 ± 0.26; (D) 0.41 ± 0.25; (E) 0.23 ± 0.25; (F) 0.08 ± 0.09;
(G) 0.55 ± 0.21; and (H) 0.43 ± 0.22. There was a trend for
higher utility values to be associated with better outcomes and
lower utility values to be associated with poorer outcomes.
CONCLUSIONS: The trends in the utility values were consis-
tent between the general population and caregivers. There was
a concomitant decrease in the quality of life of a caregiver with
increasing severity of the patient’s condition.
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OBJECTIVES: To present preliminary baseline data on patient
and family burden associated with Attention-Deﬁcit/Hyperactiv-
ity Disorder (ADHD) symptoms in German patients enrolled in
the ADORE study (Attention Deﬁcit Hyperactivity Observa-
tional Research in Europe). METHODS: ADORE is an ongoing
24 month, pan-European, prospective, observational study to
describe the relationship between treatment regimen prescribed
and quality of life in ADHD. Only those patients were docu-
mented that had not formally been diagnosed with ADHD
before. RESULTS: In total, 392 patients with a mean age of 8.7
(SD 2.1) years with inattentive/impulsive/hyperactive symptoms
were enrolled, of which 300 (77%) were male. Patient
birth/maternity problems included: smoking in 57 cases (15%),
maternal drug/alcohol abuse in 8 cases (2%), 37 patients (9%)
were born prematurely, 23 (6%) had low birth weight, and in
79 cases (20%) other birth/maternity problems were experi-
enced. Past history of inattentive/impulsive/hyperactive symp-
toms in the immediate family was reported for 171 patients
(44%), 29 cases (7%) in the extended family, and 13 cases (3%)
in both the immediate and extended family. A total of 130
mothers (33%) and 41 fathers (10%) experienced emotional
problems due to the patient’s symptoms. During the last 6-
months, 47 (12%) patients experienced some exclusions from
school lessons, 48 (12%) were in special educational programs,
and 30 (8%) were requested to change to a special needs school.
Thirty-six patients/families (9%) had contact with social ser-
vices, 7 (2%) had contact with the police. Over the last 4 weeks,
134 patients (34%) were involved in bullying, as the victim (N
= 49; 13%), the bully (N = 58; 15%), or both (N = 27; 7%).
Seven patients (2%) reported current tobacco use/abuse, 2 (<1%)
cannabis use/abuse, and 4 (1%) alcohol use/abuse. CONCLU-
SIONS: Baseline data suggest that ADHD symptoms are associ-
ated with a considerable burden on patients and families in terms
of school behavior, social activities, and emotional problems.
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OBJECTIVES: The aim of this study was to investigate whether
the use of conventional antipsychotics and newer atypical
antipsychotic drugs, such as olanzapine, risperidone or quetiap-
ine, is associated with an increased incidence of diabetes melli-
tus. METHODS: Data were obtained from the PHARMO
Record Linkage System comprising pharmacy records and hos-
pitalisations of all 950,000 community-dwelling inhabitants of
18 geo-demograﬁc deﬁned areas in the The Netherlands from
1991 until 2003. In a nested case-control study among users of
antipsychotic drugs, 1365 cases and 8143 controls with a hos-
pitalisation for diabetes or who were using antidiabetic drugs
(index date) matched on age, sex, and calendar year were
selected. Use of antipsychotic drugs among cases and controls
was determined over three months prior to the index date. Con-
ditional logistic regression was performed to estimate odds ratios
and 95% conﬁdence intervals (CI). RESULTS: Compared with
no antipsychotic use, use of olanzapine, conventional antipsy-
chotic drug and other newer atypical antipsychotics, but not
risperidone (OR adjusted 1.17 (95%CI: 0.61–2.23), are associ-
ated with a signiﬁcant increase in the risk of diabetes (OR
adjusted 2.52 (95%CI: 1.21–5.26), 3.22 (95%CI: 2.70–3.84)
and 2.22 (95%CI: 1.05–4.69), respectively). Cases and controls
who used conventional antipsychotic drugs were older than the
other atypical antipsychotic drug groups. CONCLUSIONS: Our
results suggest that use of conventional antipsychotics, olanzap-
ine, and other newer antipsychotics (clozapine, sertindole and
remoxipride), but not risperidone, was consistently associated
with an increased risk of diabetes. It is therefore important to
stress that the metabolic consequences of antipsychotic drug
therapy should be considered by the treating physicians.
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OBJECTIVE: This is the ﬁrst study to estimate the impact of dia-
betes on the probability of working and weekly work hours for
Canadian with insulin dependent diabetes (IDDM) and non-
insulin dependent diabetes (NIDDM) and diabetes related
comorbidities/complications. METHODS: Two-part model were
performed to predict the weekly work hours (after adjusting for
other chronic disorders and socio-demographic) of diabetics
among respondent to the Canadian Community Health Survey
2001. Logistics regression and multiple OLS analyses were used
to predict the probability of employment and weekly work
hours. RESULTS: Women and men with IDDM had lower prob-
ability of having job by 10% and 5%, respectively compared
with healthy groups. These probabilities were smaller for women
